-
Mashup Score: 18A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against the use of remdesivir in hospitalised patients with…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 4A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against the use of remdesivir in hospitalised patients with…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#BMJInfographic—Remdesivir is not recommended for patients admitted to hospital with covid-19, regardless of how severely ill they are. Read the full recommendation and interactive graphic: https://t.co/NK5zhZJcps #RapidRecs @will_s_t https://t.co/rcjOZNfM4p
-
-
Mashup Score: 20Remdesivir for severe covid-19: a clinical practice guideline - 4 year(s) ago
Clinical question What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020. Current practice Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. After rapid market approval in the US, remdesivir is already being used in…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
BMJ Rapid Recommendation makes a weak recommendation for the use of remdesivir for patients with severe #COVID19. The authors strongly support continued enrolment of patients into ongoing clinical trials https://t.co/RQW2gAk2Wg #RapidRecs
-
-
Mashup Score: 25Remdesivir for severe covid-19: a clinical practice guideline - 4 year(s) ago
Clinical question What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020. Current practice Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. After rapid market approval in the US, remdesivir is already being used in…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
BMJ Rapid Recommendation makes a weak recommendation for the use of remdesivir for patients with severe #COVID19. The authors strongly support continued enrolment of patients into ongoing clinical trials https://t.co/beteYZKypV #RapidRecs
-
-
Mashup Score: 7Remdesivir for severe covid-19: a clinical practice guideline - 4 year(s) ago
Clinical question What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020. Current practice Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. After rapid market approval in the US, remdesivir is already being used in…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
NEW BMJ Rapid Recommendation makes a weak recommendation for the use of remdesivir for patients with severe #COVID19. The authors strongly support continued enrolment of patients into ongoing clinical trials https://t.co/3lV4ESUIiO #RapidRecs
-
-
Mashup Score: 29Remdesivir for severe covid-19: a clinical practice guideline - 4 year(s) ago
Clinical question What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020. Current practice Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. After rapid market approval in the US, remdesivir is already being used in…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
NEW BMJ Rapid Recommendation makes a weak recommendation for the use of remdesivir for patients with severe #COVID19. The authors strongly support continued enrolment of patients into ongoing clinical trials https://t.co/AP8ptlylTp #RapidRecs
-
#BMJInfographic—Remdesivir is not recommended for patients admitted to hospital with covid-19, regardless of how severely ill they are. Read the full recommendation and interactive graphic: https://t.co/IDHP7LfWi6 #RapidRecs @will_s_t https://t.co/OQi3i8w5Ug